Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 17 studies | 26% ± 10% | |
glutamatergic neuron | 11 studies | 42% ± 25% | |
macrophage | 11 studies | 30% ± 12% | |
classical monocyte | 9 studies | 26% ± 10% | |
microglial cell | 8 studies | 28% ± 9% | |
myeloid cell | 8 studies | 25% ± 7% | |
adipocyte | 8 studies | 25% ± 4% | |
fibroblast | 8 studies | 23% ± 7% | |
oligodendrocyte | 8 studies | 27% ± 8% | |
monocyte | 7 studies | 31% ± 13% | |
oligodendrocyte precursor cell | 7 studies | 26% ± 11% | |
GABAergic neuron | 7 studies | 44% ± 22% | |
astrocyte | 7 studies | 29% ± 12% | |
interneuron | 6 studies | 41% ± 24% | |
dendritic cell | 6 studies | 25% ± 4% | |
endothelial cell of lymphatic vessel | 6 studies | 32% ± 13% | |
neuron | 5 studies | 37% ± 21% | |
epithelial cell | 5 studies | 33% ± 11% | |
smooth muscle cell | 5 studies | 20% ± 2% | |
natural killer cell | 4 studies | 22% ± 4% | |
granule cell | 4 studies | 23% ± 5% | |
mast cell | 4 studies | 21% ± 4% | |
lymphocyte | 4 studies | 25% ± 9% | |
type I pneumocyte | 4 studies | 21% ± 6% | |
neutrophil | 3 studies | 28% ± 9% | |
hematopoietic precursor cell | 3 studies | 43% ± 13% | |
non-classical monocyte | 3 studies | 23% ± 5% | |
GABAergic interneuron | 3 studies | 26% ± 3% | |
mononuclear phagocyte | 3 studies | 22% ± 5% | |
ciliated cell | 3 studies | 24% ± 5% | |
hepatocyte | 3 studies | 55% ± 19% | |
T cell | 3 studies | 20% ± 3% | |
alveolar macrophage | 3 studies | 35% ± 13% | |
type II pneumocyte | 3 studies | 21% ± 7% | |
basal cell | 3 studies | 31% ± 16% | |
goblet cell | 3 studies | 35% ± 23% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 5758.96 | 1445 / 1445 | 100% | 34.06 | 183 / 183 |
lung | 100% | 5773.56 | 578 / 578 | 100% | 37.12 | 1155 / 1155 |
stomach | 100% | 3688.56 | 359 / 359 | 100% | 34.32 | 286 / 286 |
breast | 100% | 4903.78 | 459 / 459 | 100% | 37.09 | 1117 / 1118 |
thymus | 100% | 4997.22 | 653 / 653 | 100% | 43.07 | 604 / 605 |
intestine | 100% | 4971.27 | 966 / 966 | 100% | 36.85 | 526 / 527 |
uterus | 100% | 7522.80 | 170 / 170 | 100% | 34.25 | 458 / 459 |
liver | 100% | 4175.56 | 226 / 226 | 100% | 27.23 | 405 / 406 |
bladder | 100% | 6177.62 | 21 / 21 | 100% | 32.52 | 502 / 504 |
ovary | 100% | 3664.81 | 180 / 180 | 100% | 26.18 | 428 / 430 |
skin | 100% | 6129.76 | 1809 / 1809 | 99% | 37.73 | 469 / 472 |
prostate | 100% | 4047.66 | 245 / 245 | 99% | 21.28 | 498 / 502 |
pancreas | 99% | 2133.02 | 325 / 328 | 99% | 28.80 | 176 / 178 |
kidney | 100% | 3816.19 | 89 / 89 | 98% | 27.85 | 879 / 901 |
brain | 97% | 2367.00 | 2556 / 2642 | 100% | 25.53 | 705 / 705 |
adrenal gland | 100% | 4896.44 | 258 / 258 | 95% | 21.11 | 219 / 230 |
adipose | 100% | 5781.96 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 26.70 | 29 / 29 |
muscle | 100% | 3133.33 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 8725.31 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 33.87 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 24.75 | 1 / 1 |
blood vessel | 100% | 4465.70 | 1334 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 100% | 15720.24 | 926 / 929 | 0% | 0 | 0 / 0 |
heart | 98% | 2635.29 | 841 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 96% | 29.50 | 77 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006366 | Biological process | transcription by RNA polymerase II |
GO_0032495 | Biological process | response to muramyl dipeptide |
GO_0002062 | Biological process | chondrocyte differentiation |
GO_0006935 | Biological process | chemotaxis |
GO_0002862 | Biological process | negative regulation of inflammatory response to antigenic stimulus |
GO_0002021 | Biological process | response to dietary excess |
GO_0090090 | Biological process | negative regulation of canonical Wnt signaling pathway |
GO_0030168 | Biological process | platelet activation |
GO_0010831 | Biological process | positive regulation of myotube differentiation |
GO_1900015 | Biological process | regulation of cytokine production involved in inflammatory response |
GO_2000379 | Biological process | positive regulation of reactive oxygen species metabolic process |
GO_0000902 | Biological process | cell morphogenesis |
GO_0038066 | Biological process | p38MAPK cascade |
GO_0035924 | Biological process | cellular response to vascular endothelial growth factor stimulus |
GO_0006006 | Biological process | glucose metabolic process |
GO_0007166 | Biological process | cell surface receptor signaling pathway |
GO_0035331 | Biological process | negative regulation of hippo signaling |
GO_0001525 | Biological process | angiogenesis |
GO_0007178 | Biological process | cell surface receptor protein serine/threonine kinase signaling pathway |
GO_0007519 | Biological process | skeletal muscle tissue development |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0001649 | Biological process | osteoblast differentiation |
GO_0007165 | Biological process | signal transduction |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0042307 | Biological process | positive regulation of protein import into nucleus |
GO_0051149 | Biological process | positive regulation of muscle cell differentiation |
GO_0045663 | Biological process | positive regulation of myoblast differentiation |
GO_0051403 | Biological process | stress-activated MAPK cascade |
GO_0071223 | Biological process | cellular response to lipoteichoic acid |
GO_0045648 | Biological process | positive regulation of erythrocyte differentiation |
GO_0071222 | Biological process | cellular response to lipopolysaccharide |
GO_0031098 | Biological process | stress-activated protein kinase signaling cascade |
GO_0060348 | Biological process | bone development |
GO_0071479 | Biological process | cellular response to ionizing radiation |
GO_0042770 | Biological process | signal transduction in response to DNA damage |
GO_0000077 | Biological process | DNA damage checkpoint signaling |
GO_0030316 | Biological process | osteoclast differentiation |
GO_0043536 | Biological process | positive regulation of blood vessel endothelial cell migration |
GO_0060045 | Biological process | positive regulation of cardiac muscle cell proliferation |
GO_0099179 | Biological process | regulation of synaptic membrane adhesion |
GO_0051146 | Biological process | striated muscle cell differentiation |
GO_0071493 | Biological process | cellular response to UV-B |
GO_0048010 | Biological process | vascular endothelial growth factor receptor signaling pathway |
GO_0001502 | Biological process | cartilage condensation |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0031663 | Biological process | lipopolysaccharide-mediated signaling pathway |
GO_0018105 | Biological process | peptidyl-serine phosphorylation |
GO_0035994 | Biological process | response to muscle stretch |
GO_0046326 | Biological process | positive regulation of glucose import |
GO_0019395 | Biological process | fatty acid oxidation |
GO_0032735 | Biological process | positive regulation of interleukin-12 production |
GO_0032868 | Biological process | response to insulin |
GO_0090400 | Biological process | stress-induced premature senescence |
GO_0001890 | Biological process | placenta development |
GO_1901741 | Biological process | positive regulation of myoblast fusion |
GO_0098586 | Biological process | cellular response to virus |
GO_0071356 | Biological process | cellular response to tumor necrosis factor |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0090336 | Biological process | positive regulation of brown fat cell differentiation |
GO_0070935 | Biological process | 3'-UTR-mediated mRNA stabilization |
GO_0006915 | Biological process | apoptotic process |
GO_0090398 | Biological process | cellular senescence |
GO_0048863 | Biological process | stem cell differentiation |
GO_0031281 | Biological process | positive regulation of cyclase activity |
GO_0046323 | Biological process | glucose import |
GO_0030278 | Biological process | regulation of ossification |
GO_0098978 | Cellular component | glutamatergic synapse |
GO_1904813 | Cellular component | ficolin-1-rich granule lumen |
GO_0005634 | Cellular component | nucleus |
GO_0005576 | Cellular component | extracellular region |
GO_0000922 | Cellular component | spindle pole |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005739 | Cellular component | mitochondrion |
GO_0034774 | Cellular component | secretory granule lumen |
GO_0005737 | Cellular component | cytoplasm |
GO_0016607 | Cellular component | nuclear speck |
GO_0005829 | Cellular component | cytosol |
GO_0004708 | Molecular function | MAP kinase kinase activity |
GO_0005524 | Molecular function | ATP binding |
GO_0004707 | Molecular function | MAP kinase activity |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0051525 | Molecular function | NFAT protein binding |
GO_0019899 | Molecular function | enzyme binding |
GO_0048273 | Molecular function | mitogen-activated protein kinase p38 binding |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0005515 | Molecular function | protein binding |
GO_0019903 | Molecular function | protein phosphatase binding |
Gene name | MAPK14 |
Protein name | Mitogen-activated protein kinase 14 (EC 2.7.11.24) (Mitogen-activated protein kinase p38 alpha) mitogen-activated protein kinase (EC 2.7.11.24) Mitogen-activated protein kinase 14 (MAP kinase 14) (MAPK 14) (EC 2.7.11.24) (Cytokine suppressive anti-inflammatory drug-binding protein) (CSAID-binding protein) (CSBP) (MAP kinase MXI2) (MAX-interacting protein 2) (Mitogen-activated protein kinase p38 alpha) (MAP kinase p38 alpha) (Stress-activated protein kinase 2a) (SAPK2a) |
Synonyms | CSPB1 hCG_1818055 SAPK2A CSBP1 MXI2 CSBP2 CSBP |
Description | FUNCTION: Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. MAPK14 is one of the four p38 MAPKs which play an important role in the cascades of cellular responses evoked by extracellular stimuli such as pro-inflammatory cytokines or physical stress leading to direct activation of transcription factors. Accordingly, p38 MAPKs phosphorylate a broad range of proteins and it has been estimated that they may have approximately 200 to 300 substrates each. Some of the targets are downstream kinases which are activated through phosphorylation and further phosphorylate additional targets. RPS6KA5/MSK1 and RPS6KA4/MSK2 can directly phosphorylate and activate transcription factors such as CREB1, ATF1, the NF-kappa-B isoform RELA/NFKB3, STAT1 and STAT3, but can also phosphorylate histone H3 and the nucleosomal protein HMGN1 . RPS6KA5/MSK1 and RPS6KA4/MSK2 play important roles in the rapid induction of immediate-early genes in response to stress or mitogenic stimuli, either by inducing chromatin remodeling or by recruiting the transcription machinery . On the other hand, two other kinase targets, MAPKAPK2/MK2 and MAPKAPK3/MK3, participate in the control of gene expression mostly at the post-transcriptional level, by phosphorylating ZFP36 (tristetraprolin) and ELAVL1, and by regulating EEF2K, which is important for the elongation of mRNA during translation. MKNK1/MNK1 and MKNK2/MNK2, two other kinases activated by p38 MAPKs, regulate protein synthesis by phosphorylating the initiation factor EIF4E2 . MAPK14 interacts also with casein kinase II, leading to its activation through autophosphorylation and further phosphorylation of TP53/p53 . In the cytoplasm, the p38 MAPK pathway is an important regulator of protein turnover. For example, CFLAR is an inhibitor of TNF-induced apoptosis whose proteasome-mediated degradation is regulated by p38 MAPK phosphorylation. In a similar way, MAPK14 phosphorylates the ubiquitin ligase SIAH2, regulating its activity towards EGLN3 . MAPK14 may also inhibit the lysosomal degradation pathway of autophagy by interfering with the intracellular trafficking of the transmembrane protein ATG9 . Another function of MAPK14 is to regulate the endocytosis of membrane receptors by different mechanisms that impinge on the small GTPase RAB5A. In addition, clathrin-mediated EGFR internalization induced by inflammatory cytokines and UV irradiation depends on MAPK14-mediated phosphorylation of EGFR itself as well as of RAB5A effectors . Ectodomain shedding of transmembrane proteins is regulated by p38 MAPKs as well. In response to inflammatory stimuli, p38 MAPKs phosphorylate the membrane-associated metalloprotease ADAM17 . Such phosphorylation is required for ADAM17-mediated ectodomain shedding of TGF-alpha family ligands, which results in the activation of EGFR signaling and cell proliferation. Another p38 MAPK substrate is FGFR1. FGFR1 can be translocated from the extracellular space into the cytosol and nucleus of target cells, and regulates processes such as rRNA synthesis and cell growth. FGFR1 translocation requires p38 MAPK activation. In the nucleus, many transcription factors are phosphorylated and activated by p38 MAPKs in response to different stimuli. Classical examples include ATF1, ATF2, ATF6, ELK1, PTPRH, DDIT3, TP53/p53 and MEF2C and MEF2A . The p38 MAPKs are emerging as important modulators of gene expression by regulating chromatin modifiers and remodelers. The promoters of several genes involved in the inflammatory response, such as IL6, IL8 and IL12B, display a p38 MAPK-dependent enrichment of histone H3 phosphorylation on 'Ser-10' (H3S10ph) in LPS-stimulated myeloid cells. This phosphorylation enhances the accessibility of the cryptic NF-kappa-B-binding sites marking promoters for increased NF-kappa-B recruitment. Phosphorylates CDC25B and CDC25C which is required for binding to 14-3-3 proteins and leads to initiation of a G2 delay after ultraviolet radiation . Phosphorylates TIAR following DNA damage, releasing TIAR from GADD45A mRNA and preventing mRNA degradation . The p38 MAPKs may also have kinase-independent roles, which are thought to be due to the binding to targets in the absence of phosphorylation. Protein O-Glc-N-acylation catalyzed by the OGT is regulated by MAPK14, and, although OGT does not seem to be phosphorylated by MAPK14, their interaction increases upon MAPK14 activation induced by glucose deprivation. This interaction may regulate OGT activity by recruiting it to specific targets such as neurofilament H, stimulating its O-Glc-N-acylation. Required in mid-fetal development for the growth of embryo-derived blood vessels in the labyrinth layer of the placenta. Also plays an essential role in developmental and stress-induced erythropoiesis, through regulation of EPO gene expression . Isoform MXI2 activation is stimulated by mitogens and oxidative stress and only poorly phosphorylates ELK1 and ATF2. Isoform EXIP may play a role in the early onset of apoptosis. Phosphorylates S100A9 at 'Thr-113' . Phosphorylates NLRP1 downstream of MAP3K20/ZAK in response to UV-B irradiation and ribosome collisions, promoting activation of the NLRP1 inflammasome and pyroptosis . .; FUNCTION: (Microbial infection) Activated by phosphorylation by M.tuberculosis EsxA in T-cells leading to inhibition of IFN-gamma production; phosphorylation is apparent within 15 minutes and is inhibited by kinase-specific inhibitors SB203580 and siRNA . . |
Accessions | ENST00000468133.5 ENST00000310795.8 [Q16539-4] ENST00000229794.9 [Q16539-1] ENST00000474429.5 ENST00000472333.1 Q16539 B5TY33 B4E0K5 ENST00000491957.5 E7EX54 L7RSM2 ENST00000229795.8 [Q16539-2] H7C4E2 |